|
|||||
|
|
||||||
Erratum
for
Alberts et al., Journal of Clinical Oncology, Vol 10, 1505, Copyright © 1992 by American Society of Clinical Oncology
Improved Therapeutic Index of Carboplatin Plus Cyclophosphamide Versus Cisplatin Plus CyclophosphamideFinal Report by the Southwest Oncology Group of a Phase III Randomized Trial in Stages III and IV Ovarian Cancer
There was an error in Table 9 of the report "Improved Therapeutic Index of Carboplatin Plus Cyclophosphamide Versus Cisplatin Plus Cyclophosphamide: Final Report by the Southwest Oncology Group of a Phase III Randomized Trial in Stages III and IV Ovarian Cancer" by Alberts et al (J Clin Oncol 10:706717, 1992). The dosage of cisplatin given in the table for the report by Kato et al (cited as reference 21) should have been 50 mg/m2. The table is reprinted here correctly in its entirety: Please see the PDF for Table.
|
|
|||||||||||
|
Copyright © 1992 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
|